Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 4,619 | reported | 02 Mar 2026 | tx 67+259,208−218,762 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | SALE | AbbVie Inc. | 10,291 | 234.66 USD | |
| 02 Mar 2026 | SALE | AbbVie Inc. | 2,600 | 235.26 USD | |
| 02 Mar 2026 | SALE | AbbVie Inc. | 5,777 | 233.51 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | AbbVie Inc. | 14,850 | 232.08 USD | |
| 25 Feb 2026 | EXERCISE | AbbVie Inc. | 7,292 | 192.86 USD | |
| 25 Feb 2026 | EXERCISE | AbbVie Inc. | 7,314 | 149.62 USD | |
| 25 Feb 2026 | EXERCISE | AbbVie Inc. | 7,775 | 175.28 USD | |
| 25 Feb 2026 | SALE | AbbVie Inc. | 22,381 | 230.00 USD | |
| 25 Feb 2026 | EXERCISE | AbbVie Inc. | 7,314 | 149.62 USD | deriv |
| 25 Feb 2026 | EXERCISE | AbbVie Inc. | 7,775 | 175.28 USD | deriv |
| 25 Feb 2026 | EXERCISE | AbbVie Inc. | 7,292 | 192.86 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 5,808 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 16,290 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 5,628 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 5,792 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 19,500 | 0.00 USD | deriv |
| 28 Feb 2025 | SALE | AbbVie Inc. | 6,811 | 206.62 USD | |
| 28 Feb 2025 | SALE | AbbVie Inc. | 363 | 207.19 USD | |
| 03 Mar 2025 | EXERCISE | AbbVie Inc. | 2,918 | 144.54 USD | |
| 03 Mar 2025 | EXERCISE | AbbVie Inc. | 7,775 | 175.28 USD | |
| 03 Mar 2025 | SALE | AbbVie Inc. | 18,008 | 210.00 USD | |
| 03 Mar 2025 | EXERCISE | AbbVie Inc. | 7,315 | 149.62 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 7,870 | 205.02 USD | |
| 28 Feb 2025 | SALE | AbbVie Inc. | 2,718 | 205.38 USD | |
| 03 Mar 2025 | OTHER | AbbVie Inc. | 7,775 | 175.28 USD | deriv |